Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.
Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, Sidiropoulos P, Vassilopoulos D. Thomas K, et al. Among authors: fragiadaki k. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):254-262. Epub 2017 Nov 9. Clin Exp Rheumatol. 2018. PMID: 29148406
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Karanikolas GN, Koukli EM, Katsalira A, Arida A, Petrou D, Komninou E, Fragiadaki K, Zacharioudaki A, Lasithiotakis I, Giavri E, Vaiopoulos G, Sfikakis PP. Karanikolas GN, et al. Among authors: fragiadaki k. J Rheumatol. 2011 Nov;38(11):2466-74. doi: 10.3899/jrheum.110242. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885499 Clinical Trial.
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
Karamanakos A, Evangelatos G, Pappa M, Fragiadaki K, Fanouriakis A, Fragoulis GE. Karamanakos A, et al. Among authors: fragiadaki k. J Rheumatol. 2022 Nov;49(11):1295-1296. doi: 10.3899/jrheum.220487. Epub 2022 Aug 1. J Rheumatol. 2022. PMID: 35914789 No abstract available.
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C, Zioga N, Papadopoulos V, Gerolymatou N, Kalavri E, Bounos C, Simopoulou T, Fragoulis GE, Panopoulos S, Fragiadaki K, Evangelatos G, Bournia VK, Arida A, Karamanakos A, Pappa M, Kravvariti E, Deftereou K, Kougkas N, Zampeli E, Kataxaki E, Melissaropoulos K, Barouta G, Panagiotopoulos A, Koutsianas C, Liossis SN, Georgiou P, Dimitroulas T, Tektonidou MG, Bogdanos DP, Elezoglou A, Voulgari PV, Sfikakis PP, Vassilopoulos D. Papagoras C, et al. Among authors: fragiadaki k. Clin Rheumatol. 2023 Dec;42(12):3375-3385. doi: 10.1007/s10067-023-06769-4. Epub 2023 Sep 21. Clin Rheumatol. 2023. PMID: 37731083 Free PMC article.
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
Fragoulis GE, Bournia VK, Mavrea E, Evangelatos G, Fragiadaki K, Karamanakos A, Kravariti E, Laskari K, Panopoulos S, Pappa M, Mitsikostas DD, Tektonidou MG, Vassilopoulos D, Sfikakis PP. Fragoulis GE, et al. Among authors: fragiadaki k. Rheumatol Int. 2022 Jan;42(1):31-39. doi: 10.1007/s00296-021-05039-3. Epub 2021 Nov 5. Rheumatol Int. 2022. PMID: 34739573 Free PMC article.
35 results